Paper691003
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
Petersen HJ and 2 others. J Med Chem, 1978. Cited by 119 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines. Papers, record 691003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/691003
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Guanidines | Major topic |
| Animals | |
| Dogs | |
| Female | |
| Hypertension | |
| Lethal Dose 50 | |
| Mice | |
| Rats | |
| Structure-Activity Relationship |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34025808 | Synthetic accesses to biguanide compounds. | Beilstein J Org Chem | 2021 | https://conductscience.org/library/papers/34025808 | PubMed |
| 26935206 | Combinatorial phenotypic screen uncovers unrecognized family of extended thiourea inhibitors with copper-dependent anti-staphylococcal activity. | Metallomics | 2016 | https://conductscience.org/library/papers/26935206 | PubMed |
| 7783838 | Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism. | Neurochem Res | 1995 | https://conductscience.org/library/papers/7783838 | PubMed |
| 7647022 | Pharmacology of the potassium channel openers. | Cardiovasc Drugs Ther | 1995 | https://conductscience.org/library/papers/7647022 | PubMed |
| 7379920 | N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator. | Experientia | 1980 | https://conductscience.org/library/papers/7379920 | PubMed |
| 6974455 | An unusual profile of activity of a new basic anti-inflammatory drug, timegadine. | Agents Actions | 1981 | https://conductscience.org/library/papers/6974455 | PubMed |
| 6653652 | Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6653652 | PubMed |
| 6468476 | Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6468476 | PubMed |
| 4029244 | Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4029244 | PubMed |
| 4029243 | Long-term effects of pinacidil in hypertensive dialysis patients. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4029243 | PubMed |
| 4007040 | Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4007040 | PubMed |
| 3978025 | Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3978025 | PubMed |
| 3899669 | Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3899669 | PubMed |
| 3803413 | Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3803413 | PubMed |
| 3076134 | Pinacidil. Preclinical investigations. | Drugs | 1988 | https://conductscience.org/library/papers/3076134 | PubMed |
| 2855517 | In vitro studies on the mode of action of pinacidil. | Drugs | 1988 | https://conductscience.org/library/papers/2855517 | PubMed |
| 2848206 | The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. | Naunyn Schmiedebergs Arch Pharmacol | 1988 | https://conductscience.org/library/papers/2848206 | PubMed |
| 2674897 | Smooth muscle K+ channel openers; their pharmacology and clinical potential. | Pflugers Arch | 1989 | https://conductscience.org/library/papers/2674897 | PubMed |
| 2488102 | Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2488102 | PubMed |
| 2196168 | Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. | Drugs | 1990 | https://conductscience.org/library/papers/2196168 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/691003
GET https://conductscience.org/api/papers/v1/691003/cited_by?page=2